Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
August 7, 2007
Dynamic glass transition in two dimensions
M Bayer, J M Brader, F Ebert, et al.
Archives of Toxicology
|
April 1, 2018
Arsenic-containing hydrocarbons: effects on gene expression, epigenetics, and biotransformation in HepG2 cells
S M Müller, H Finke, F Ebert, et al.
Archives of Toxicology
|
October 24, 2017
Effects of arsenolipids on in vitro blood-brain barrier model
S M Müller, F Ebert, G Raber, et al.
Circulation Research
|
June 11, 2016
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases
Ray F Ebert, Narasimhan S Danthi, Marc F Charette, et al.
Stem Cells Translational Medicine
|
December 20, 2015
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Samuel Golpanian, Ivonne H Schulman, Ray F Ebert, et al.
Circulation Research
|
May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network
Robert D Simari, Carl J Pepine, Jay H Traverse, et al.
American Heart Journal
|
December 17, 2016
Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study
Bharath Ambale Venkatesh, Victor Nauffal, Chikara Noda, et al.
American Heart Journal
|
December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells
Emerson C Perin, Michael Murphy, John P Cooke, et al.
Cardiovascular Research
|
August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use
Doris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
August 7, 2007
Dynamic glass transition in two dimensions
M Bayer, J M Brader, F Ebert, et al.
Archives of Toxicology
|
April 1, 2018
Arsenic-containing hydrocarbons: effects on gene expression, epigenetics, and biotransformation in HepG2 cells
S M Müller, H Finke, F Ebert, et al.
Archives of Toxicology
|
October 24, 2017
Effects of arsenolipids on in vitro blood-brain barrier model
S M Müller, F Ebert, G Raber, et al.
Circulation Research
|
June 11, 2016
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases
Ray F Ebert, Narasimhan S Danthi, Marc F Charette, et al.
Stem Cells Translational Medicine
|
December 20, 2015
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Samuel Golpanian, Ivonne H Schulman, Ray F Ebert, et al.
Circulation Research
|
May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network
Robert D Simari, Carl J Pepine, Jay H Traverse, et al.
American Heart Journal
|
December 17, 2016
Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study
Bharath Ambale Venkatesh, Victor Nauffal, Chikara Noda, et al.
American Heart Journal
|
December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells
Emerson C Perin, Michael Murphy, John P Cooke, et al.
Cardiovascular Research
|
August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use
Doris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Page
of 11